Sinjard-L 10 mg Tablet is a combination of Empagliflozin and Linagliptin, used to manage Type 2 Diabetes Mellitus. Empagliflozin lowers blood sugar by increasing glucose excretion, while Linagliptin works by increasing insulin release in response to meals and reducing the production of glucose in the liver.
It is typically prescribed for patients who require better control of their blood sugar levels and can be used alone or in combination with other antidiabetic medications.